JANICE JAMES-WEBB: Open Payments
NPI 1285353532 · LAUREL, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,491 in 14 payments from 11 companies in 2025. Trend: 2023 $418 · 2024 $826 · 2025 $1,491
Food & beverage: $1,491
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 2 | $257 |
| AstraZeneca Pharmaceuticals LP | 2 | $248 |
| Amgen Inc. | 2 | $220 |
| Gilead Sciences, Inc. | 1 | $125 |
| Verona Pharma, Inc. | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| Novo Nordisk Inc | 1 | $120 |
| Actelion Pharmaceuticals US, Inc. | 1 | $90 |
| GlaxoSmithKline, LLC. | 1 | $69 |
| Axsome Therapeutics, Inc. | 1 | $59 |
Products named: FASENRA, GVOKE HYPOPEN, Epclusa, Ohtuvayre, KRYSTEXXA, VOQUEZNA, RECORLEV, Wegovy.
Industry payments across DE — which companies pay providers there.
